For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Once enabled, click here to view the site.

singup link button why should I sign up?
Login as Volunteer Login as Study team member
OR

Studies you may be eligible for. 8

Based on the information you provided, we found the following studies.

  • Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and Graft-versus-host Disease in Allogeneic Hematopoietic Cell Transplantation for High-risk Hematologic Malignancies Investigational drug carfilzomib will be added to a standard chemotherapy conditioning regimen for donor blood stem cell transplant to test if this new conditioning regimen can lead to safe and more effective stem cell transplant treatment approach for patients with quickly worsening blood cancers. This study is researching all of the following topics: ALL ( Acute lymphoblastic leukemia ) AML ( Acute myeloid leukemia ) Amyloidosis CLL ( Chronic lymphocytic leukemia) Leukemia Lymphoma MDS ( Myelodysplastic syndrome ) Multiple myeloma Myelofibrosis Non-Hodgkin's lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
    • Less than 66 years old
  • Open-label, single-center phase II study of MLN9708 (Ixazomib) in patients with relapsed/refractory cutaneous and peripheral T-cell Lymphomas The main purpose of this study is to determine if MLN9708, an investigational drug, will work against cutaneous or peripheral T-cell lymphoma that has failed to respond to other treatments, and to evaluate its side effects. This study is researching all of the following topics: Lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Phase I safety study of intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies This study is being done to learn whether treatment with Clostridium novyi-NT spores (NT refers to non-toxin producing) is safe and effective in patients with advanced cancers that can no longer be controlled with standard therapy or cancers for which there is no standard effective treatment. This study is researching all of the following topics: Adrenal cancer BCC, Basal cell skin cancer Bladder cancer Bone cancer Breast cancer Cervical cancer Colon Cancer ( Malignant tumor of colon ) Esophagus cancer Fallopian tube cancer HCC, Liver cancer Kidney Cancer ( Malignant tumor of kidney ) Laryngeal cancer, Cancer of the larynx, Voice box cancer Lung cancer Lymphoma NPC, Nasal cancer Oral / Mouth cancer Ovarian cancer Pancreatic cancer Prostate cancer Salivary Gland Cancer Sarcoma Squamous cell skin cancer Thyroid cancer Uterine / Uterus cancer This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • Open-Label, Multi-Center, Randomized Study of Anti-CCR4 Monoclonal Antibody KW-0761 The main purpose of this study is to determine if KW-0761, an investigational drug will work against cutaneous Tcell lymphoma (CTCL) that has failed to respond to other treatments, and to evaluate its side effects. KW-0761 will be tested in this study versus FDA CTCL treatment approved vorinostat. This study is researching all of the following topics: Lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Ibrutinib, in Combination with Bendamustine and Rituximab (BR) in Subjects With Newly Diagnosed Mantle Cell Lymphoma Experimental drug Ibrutinib is being tested to see if it may be useful in treating patients with newly diagnosed Mantle Cell Lymphoma.The study purpose is to compare the effects of Ibrutinib when it is given with Bendamustine (Treanda) and Rituximab (Rituxan) to Bendamustine and Rituximab alone. This study is researching all of the following topics: Lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • More than 18 years old
  • A Phase 1 study of crizotinib in combination with conventional chemotherapy for relapsed or refractory solid tumors or Anaplastic Large Cell Lymphoma (ALCL) This study seeks to discover if a combination of an expermental drug, Crizotinib (FDA-approved now for lung cancer), works in pediatric solid tumor cancer and a type of children's lymphoma, along with standard cancer drugs This study is researching all of the following topics: Lymphoma NB, Neuroblastoma Sarcoma This study is looking for: male female both men and women Volunteers with specific conditions
    • 1 years to 21 years
  • Low-dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction : A Phase IIB Randomized Placebo-Controlled Trial The purpose of this study is to determine whether two years of low dose tamoxifen has a beneficial effect on laboratory tests and other evaluations associated with breast cancer in female cancer survivors treated with chest radiation at a young age. This study is researching all of the following topics: Hodgkin's lymphoma Lymphoma Non-Hodgkin's lymphoma Sarcoma This study is looking for: female only women Volunteers with specific conditions
    • More than 25 years old
  • A Phase II Pilot Study of Metformin Therapy in Patients with Relapsed Chronic Lymphocytic Leukemia and untreated CLL patients with genomic deletion 11q The purpose of this study is to evaluate Metformin in the treatment of chronic lymphocytic leukemia and to find out whether it delays progression of the disease. This study is researching all of the following topics: Lymphoma This study is looking for: male female both men and women Volunteers with specific conditions
    • 18 years to 80 years